Clinical Trials

Showing trials with last updates posted in 2026.

NCT06058377 | RECRUITING | PHASE3
3680 participants

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-11-27
Completion:
2027-05-31
Conditions
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • HER2-Negative Breast Carcinoma
  • Hormone Receptor-Positive Breast Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT06051695 | RECRUITING | PHASE1/PHASE2
474 participants

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-04-03
Completion:
2028-06-30
Conditions
  • Rectal Cancer
  • Cancer
  • Solid Tumor, Adult
  • Colorectal Cancer
  • NSCLC
  • Non Small Cell Lung Cancer
  • NSCLC, Recurrent
  • Non-Small Cell Squamous Lung Cancer
  • Pancreas Cancer
  • Pancreatic Neoplasm
  • Colorectal Adenocarcinoma
  • CRC
  • Colon Cancer
  • Ovarian Cancer
  • Ovarian Neoplasms
  • Mesothelioma
  • Mesothelioma, Malignant
  • Ovary Cancer
  • Lung Cancer
  • MESOM
Interventions
  • BIOLOGICAL
  • DIAGNOSTIC_TEST
No Results Yet
NCT06001918 | RECRUITING | PHASE2/PHASE3
400 participants

Nectero EAST System Clinical Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2023-10-25
Completion:
2028-06-30
Conditions
  • Abdominal Aortic Aneurysm
Interventions
  • DRUG
No Results Yet
NCT05987241 | RECRUITING | PHASE2/PHASE3
992 participants

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-02-02
Completion:
2030-09-02
Conditions
  • Muscle Invasive Bladder Urothelial Carcinoma
  • Muscle Invasive Renal Pelvis Urothelial Carcinoma
  • Muscle Invasive Ureter Urothelial Carcinoma
  • Muscle Invasive Urethral Urothelial Carcinoma
  • Stage II Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage III Bladder Urothelial Carcinoma AJCC v6 and v7
  • Stage IV Bladder Urothelial Carcinoma AJCC v7
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT05773274 | RECRUITING | PHASE2
100 participants

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-26
Start Date:
2024-01-12
Completion:
2029-04-30
Conditions
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Digestive System Neuroendocrine Tumor G2
  • Unresectable Digestive System Neuroendocrine Tumor G1
  • Unresectable Digestive System Neuroendocrine Tumor G2
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page